Literature DB >> 12582159

A new beta-catenin-dependent activation domain in T cell factor.

Fawzia A Atcha1, Jesus E Munguia, Tony W H Li, Karine Hovanes, Marian L Waterman.   

Abstract

Transcription of the lymphoid enhancer factor-1 (LEF1) gene is aberrantly activated in sporadic colon cancer, whereas this gene is not expressed in the normal adult colon. We have shown previously that promoter 1 of the LEF1 gene is activated by T cell factor (TCF)-beta-catenin complexes in transient transfection assays, suggesting that LEF1 is a target of the Wnt pathway in colon cancer. To further explore the link between LEF1 expression and the Wnt pathway, we studied two response elements in the promoter. Surprisingly we found that the LEF1 promoter is selectively activated by specific isoforms of the LEF/TCF transcription factor family that contain an alternative C-terminal "E" tail. These isoforms, TCF-1E and TCF-4E, activate the promoter in a beta-catenin-dependent manner. We show that a complete E-tail domain is necessary for full activity and delimits residues within two highly conserved peptide motifs within the tail that are required (KKCRARFG; WCXXCRRKKKC). These peptide motifs are not only conserved among the TCF family members but are also found in two newly identified DNA-binding proteins named papillomavirus binding factor and GLUT4 enhancer factor. This study thus identifies a new and unique set of motifs used by the Wnt pathway for target gene regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12582159     DOI: 10.1074/jbc.M213218200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.

Authors:  Luke H Hoeppner; Frank J Secreto; David F Razidlo; Tiffany J Whitney; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

Review 2.  Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.

Authors:  Catherine D Mao; Stephen W Byers
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

3.  A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.

Authors:  Nate P Hoverter; Ju-Hui Ting; Suman Sundaresh; Pierre Baldi; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

4.  MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.

Authors:  Hasan Rajabi; Rehan Ahmad; Caining Jin; Michio Kosugi; Maroof Alam; Maya Datt Joshi; Donald Kufe
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

5.  The glucose transporter (GLUT4) enhancer factor is required for normal wing positioning in Drosophila.

Authors:  Umar Yazdani; Zhiyu Huang; Jonathan R Terman
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

6.  Differential control of Wnt target genes involves epigenetic mechanisms and selective promoter occupancy by T-cell factors.

Authors:  Simon Wöhrle; Britta Wallmen; Andreas Hecht
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

7.  Characterization of Lef-1 promoter segments that facilitate inductive developmental expression in skin.

Authors:  Xiaoming Liu; Ryan R Driskell; Meihui Luo; Duane Abbott; Mohammed Filali; Ningli Cheng; Curt D Sigmund; John F Engelhardt
Journal:  J Invest Dermatol       Date:  2004-08       Impact factor: 8.551

8.  Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.

Authors:  Claudio Sustmann; Henrik Flach; Hanna Ebert; Quinn Eastman; Rudolf Grosschedl
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

9.  No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.

Authors:  Ludmila Prokunina-Olsson; Jennifer L Hall
Journal:  Mol Cancer       Date:  2009-11-06       Impact factor: 27.401

10.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.

Authors:  Andreas Weise; Katja Bruser; Susanne Elfert; Britta Wallmen; Yvonne Wittel; Simon Wöhrle; Andreas Hecht
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.